PR really needs to resign as CEO of NSB and put his entire focus on generating interest in PAR. While the SP fall seems to be impacting the biotech sector as a whole, PR's main priority right now needs to be to stop the slide.
PR really needs to resign as CEO of NSB and put his entire focus...
-
- There are more pages in this discussion • 885 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $92.69M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $248.1K | 939.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27695 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 22537 | 4 |
View Market Depth
| Last trade - 15.32pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |